EUVIMEDEUVIMED entdecken
Open Access

Androgen receptor and MYC transcriptomes are equilibrated in multilayer regulatory circuitries in prostate cancer

Bin Fu, Liyang Wang, Tianwei Jia, Zhao Wei, Nuosu Nama, Jiaqian Liang, Xinghua Liao, XiaMing Liu iD, Yanfei Gao, Xiaoqiang Liu, Raymond S Mao, Keshan Wang iD und 2 weitere

The Prostate · 2023

DOI: 10.1002/pros.24603 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Prostate, 2023. Verfasst von Bin Fu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, P.R.China. Hauptthemen laut MEDLINE: Receptors, Androgen, Prostatic Neoplasms. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Natural Science Foundation of Shandong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The discovery of androgen receptor (AR) having transrepression effects completes the circle of its functionalities as a typical transcription factor, which intrinsically bears dual functions of activation and repression linked to co‐factor competition and redistribution. Indeed, AR dual functions are exemplified by locus‐wide regulation of the oncogenic 8q24‐MYC region.

Methods

RT‐qPCR assay and public RNA‐profiling datasets were used to assess MYC transcription in androgen‐sensitive cell lines. Public ChIP‐seq and RNA‐Seq datasets were computed to evaluate AR‐MYC direct and indirect signatures. Gene sets in typical MYC and AR pathways were monitored to validate their cross‐talks. Bio‐informatics and chromosome conformation capture (3C) assay were performed in the AR gene locus to examine androgen‐elicited distal regulation. Finally, co‐factor re‐distribution were globally tracked between AR and MYC binding sites.

Results

In this report, we found MYC responded negatively to androgen with hypersensitivity, rivaling AR natural functions as an innate androgen effector. Furthermore, both direct and indirect AR and MYC transcriptional programs were actively in equilibration. With established androgen‐mediated versus MYC‐mediated gene subsets, we validated AR and MYC pathways were both bidirectional and extensively entangled. In addition, we determined that the AR gene locus resembled the MYC gene region and both loci were androgen‐repressed via epigenetics and chromatin architectural alterations. Significantly, transcriptional factor profiling along the prostate cancer (PCa) genome exposed that PCa transcriptomes were dynamically equilibrated between AR‐binding site and MYC‐binding site.

Conclusion

Together, our findings stratified AR‐MYC interactions that are extensively wired and intricately organized to compensate for essential PCa transcriptional programs and neutralize excessive signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, AndrogenProstatic NeoplasmsMaleHumansAndrogensTranscriptomeCell Line, TumorTranscription FactorsGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

MYCandrogen receptordual functionsequilibrationprostate cancertranscriptional circuitry

Substanzen

Receptors, AndrogenAndrogensTranscription Factors

Autor:innen und Institutionen

  • Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, P.R.China.
  • Department of Medicine, Hematology-Oncology Division, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachussetts, USA.
  • Department of Cell Development Biology, College of Life Sciences, Shaanxi Normal University, Xi'an, ShaanXi, P.R.China.
  • Department of Clinical Laboratory, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, P.R.China.
  • Shandong Engineering & Technology Research Center for Tumor Marker Detection, Jinan, Shandong, P.R.China.
  • Shandong Provincial Clinical Medicine Research Center for Clinical Laboratory, Jinan, Shandong, P.R.China.

ORCID-Profile: XiaMing Liu, Keshan Wang

Förderung

  • NCI NIH HHS
  • Natural Science Foundation of Shandong Province
  • National Natural Science Foundation of China

Zitieren

APA

Fu, B., Wang, L., Jia, T., Wei, Z., Nama, N., Liang, J., Liao, X., Liu, X., Gao, Y., Liu, X., Mao, R. S., Wang, K., Guo, J., & Chen, S. S. (2023). Androgen receptor and MYC transcriptomes are equilibrated in multilayer regulatory circuitries in prostate cancer. The Prostate. https://doi.org/10.1002/pros.24603

Vancouver

Fu B, Wang L, Jia T, Wei Z, Nama N, Liang J, et al. Androgen receptor and MYC transcriptomes are equilibrated in multilayer regulatory circuitries in prostate cancer. The Prostate. 2023. doi:10.1002/pros.24603

BibTeX
@article{Fu2023,
  author = {Fu, Bin and Wang, Liyang and Jia, Tianwei and Wei, Zhao and Nama, Nuosu and Liang, Jiaqian and Liao, Xinghua and Liu, XiaMing and Gao, Yanfei and Liu, Xiaoqiang and Mao, Raymond S and Wang, Keshan and Guo, Ju and Chen, Shaoyong S},
  title = {Androgen receptor and MYC transcriptomes are equilibrated in multilayer regulatory circuitries in prostate cancer},
  journal = {The Prostate},
  year = {2023},
  doi = {10.1002/pros.24603}
}
Kostenlos starten →